… In Vivo Antitumor Activity of SU11248, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial Growth Factor and Platelet-derived Growth Factor …

DB Mendel, AD Laird, X Xin, SG Louie… - Clinical cancer …, 2003 - AACR
… potent antitumor activity causing regression, growth arrest, or substantially reduced growth
of … To predict the target SU11248 exposure required to achieve antitumor activity in mouse …

… activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor …

F Ciardiello, R Bianco, R Caputo, R Caputo… - Clinical Cancer …, 2004 - AACR
… This antitumor effect was significantly different to the GEO tumor growth in mice treated …
We next evaluated whether treatment with ZD6474 could have antitumor activity in GEO tumors …

Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes

H Masui, T Moroyama, J Mendelsohn - Cancer Research, 1986 - AACR
… which bind specifically to receptors for growth factors. Our studies dem onstrated that anti-growth
factor receptor mAbs can block the access of growth factors to their receptors on tumor …

Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor …

F Ciardiello, R Bianco, V Damiano, G Fontanini… - Clinical Cancer …, 2000 - AACR
factors such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor
(… In this study, we have evaluated the antiangiogenic and antitumor activity of monoclonal …

Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors

TMJ Niederman, Z Ghogawala… - Proceedings of the …, 2002 - National Acad Sciences
… -expressing Cl96 cells possessed antitumor activity after adoptive transfer comparable to
transduced primary cells. To enable the evaluation of the activity of the chimeric TCR against …

Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A

F Ciardiello, V Damiano, R Bianco… - JNCI: Journal of the …, 1996 - academic.oup.com
growth (compared with that in control mice; P <.00001) and suppressed cancer cell production
of autocrine growth factors, … ) factors, such as vascular endothelial growth factor and basic …

Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225

F Ciardiello, R Bianco, V Damiano, S De Lorenzo… - Clinical Cancer …, 1999 - AACR
… express functional EGFR, the antiproliferative activity of MAb C225 in combination with …
antitumor activity in these malignancies. A dose-dependent supraadditive increase of growth

Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2

W Munger, SQ Dejoy, R Jeyaseelan Sr, LW Torley… - Cellular …, 1995 - Elsevier
Interleukin-15 is a new cytokine that stimulates the proliferation of T cells and other cells of
the immune system. Some of the biological properties of interleukin-15 overlap that of …

[HTML][HTML] Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor …

M Colleoni, A Rocca, MT Sandri, L Zorzino, G Masci… - Annals of …, 2002 - Elsevier
… We evaluated the clinical efficacy and impact on serum vascular endothelial growth factor
(VEGF) levels of low-dose oral MTX and CTX in patients with metastatic breast cancer. MTX …

Wide spectrum of antitumor activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor

M Asano, A Yukita, H Suzuki - Japanese journal of cancer …, 1999 - Wiley Online Library
activity in … the antitumor activity spectrum of MV833 against 27 human tumors transplanted
in nude mice and show that anti-VEGF antibody has the potential to inhibit the growth of many …